Elizabeth Theophille

Chief Technology & Digital Officer at Novartis AG

Elizabeth Theophille

Elizabeth Theophille

Chief Technology & Digital Officer at Novartis AG

Biography

Elizabeth Theophille is Chief Technology & Digital Officer at Novartis AG and Director-Information Systems at Alcatel Submarine Networks SASU. Ms. Theophille is also on the board of 8x8, Inc.

Overview
RelSci Relationships

71

Number of Boards

1

Birthday

1967

Age

52

Relationships
RelSci Relationships are individuals Elizabeth Theophille likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Technology Officer at 8x8, Inc.

Relationship likelihood: Strong

Chief Executive Officer at 8x8, Inc.

Relationship likelihood: Strong

Chief Financial Officer at Coupa Software, Inc.

Relationship likelihood: Average

Executive Vice President & Chief Marketing Officer at Akamai Technologies, Inc.

Relationship likelihood: Average

Chief Financial & Accounting Officer at 8x8, Inc.

Relationship likelihood: Average

Senior Vice President, General Counsel, Corporate Secretary & Chief Privacy Officer at 8x8, Inc.

Relationship likelihood: Average

Director of Undergraduate Studies at Princeton University - School of Engineering and Applied Sciences

Relationship likelihood: Average

Founder at Continuum Capital Partners LLC

Relationship likelihood: Average

Founder at SarniHaan Capital Partners LLC

Relationship likelihood: Average

Chief Technology Officer, Director & Executive Vice President-Products at Next Issue Media LLC

Relationship likelihood: Average

Paths to Elizabeth Theophille
Potential Connections via
Relationship Science
You
Elizabeth Theophille
Chief Technology & Digital Officer at Novartis AG
Career History
Chief Technology & Digital Officer
2016 - Current

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Director-Information Systems
Prior

Alcatel Submarine Networks SASU engages in designing and manufacturing of fiber optic cables for undersea telecommunications systems. It also provides cable laying and maintenance services for short-link, ultra-long haul, repeated, and unrepeated networks. The company is headquartered in Nozay, France.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Elizabeth Theophille is affiliated with Novartis AG, Alcatel Submarine Networks SASU

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Elizabeth Theophille. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Elizabeth Theophille's profile does not indicate a business or promotional relationship of any kind between RelSci and Elizabeth Theophille.